← Back to all trials
Recruiting
NCT07840729
Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants
Conditions: Valid MeSH Conditiongs
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: PHASE1
Enrollment: 90
Sponsor: Shanghai JMT-Bio Inc.
Location: Peking University People's Hospital Beijing
Summary
Use these resources to provide understandable information about this study to patients, families, and health care providers:
Eligibility Criteria
Inclusion Criteria:
1. Age 18\~65 (including threshold values), male or female participants;
2. BMI ≥ 30 kg/m²;
3. Weight change \
Source: ClinicalTrials.gov (NCT07840729). StuddyBuddy aggregates publicly available trial information.
